Patents by Inventor Michael David Kaufman

Michael David Kaufman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
    Patent number: 7411001
    Abstract: The present invention relates to oxygenated esters of 4-iodophenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof. The present invention also relates to crystalline forms of oxygenated esters of 4-iodophenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: August 12, 2008
    Assignee: Warner-Lambert Company
    Inventors: Stephen Douglas Barrett, Cathlin Marie Biwersi, Michael Huai Gu Chen, Michael David Kaufman, Haile Tecle, Joseph Scott Warmus
  • 5-substituted-4-[(substituted phenyl) amino]-2-pyridone derivatives
    Patent number: 7273877
    Abstract: The present invention relates to 5-substituted-4-(substituted)phenylamino-2-pyridone derivatives, pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: June 24, 2004
    Date of Patent: September 25, 2007
    Assignee: Warner-Lambert Company, LLC
    Inventors: Shannon Leigh Black, Michael David Kaufman, Daniel Fred Ortwine, Mark Stephen Plummer, John Quin, III, Gordon William Rewcastle, Aurash B. Shahripour, Julie Ann Spicer, Christopher Emil Whitehead
  • N-methyl-substituted benzamidazoles
    Patent number: 7160915
    Abstract: The present invention relates to N-methyl-substituted benzamidazole derivatives of formula (I): as defined in the specification; pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: July 22, 2004
    Date of Patent: January 9, 2007
    Assignee: Warner-Lambert Company, LLC
    Inventors: Stephen Douglas Barrett, Cathlin Marie Flamme, Michael David Kaufman, Jared Bruce John Milbank, Haile Tecle, Joseph Scott Warmus
  • N-(4 substituted phenyl)-anthranilic acid hydroxamate esters
    Patent number: 7078438
    Abstract: The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: February 4, 2005
    Date of Patent: July 18, 2006
    Assignee: Warner-Lambert Company
    Inventors: Gordon William Rewcastle, Julie Ann Spicer, Stephen Douglas Barrett, Michael David Kaufman, Jared Bruce John Milbank, Haile Tecle
  • Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
    Patent number: 6960614
    Abstract: The present invention relates to oxygenated esters of 4-iodophenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof. The present invention also relates to crystaline forms of oxygenated esters of 4-iodophenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: November 1, 2005
    Assignee: Warner-Lambert Company
    Inventors: Stephen Douglas Barrett, Cathlin Marie Biwersi, Michael David Kaufman, Haile Tecle, Joseph Scott Warmus
  • N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
    Patent number: 6891066
    Abstract: The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: January 23, 2003
    Date of Patent: May 10, 2005
    Assignee: Warner-Lambert Company
    Inventors: Gordon William Rewcastle, Julie Ann Spicer, Stephen Douglas Barrett, Michael David Kaufman, Jared Bruce John Milbank, Haile Tecle
  • N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
    Patent number: 6770778
    Abstract: The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions, and methods of use thereof.
    Type: Grant
    Filed: January 23, 2003
    Date of Patent: August 3, 2004
    Assignee: Pfizer Inc
    Inventors: Stephen Douglas Barrett, Michael David Kaufman, Gordon William Rewcastle, Julie Ann Spicer
  • Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
    Publication number: 20040054172
    Abstract: The present invention relates to oxygenated esters of 4-iodophenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof. The present invention also relates to crystaline forms of oxygenated esters of 4-iodophenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: June 19, 2003
    Publication date: March 18, 2004
    Inventors: Stephen Douglas Barrett, Cathlin Marie Biwersi, Michael Huai Gu Chen, Michael David Kaufman, Haile Tecle, Joseph Scott Warmus
  • N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
    Publication number: 20040006245
    Abstract: The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: January 23, 2003
    Publication date: January 8, 2004
    Inventors: Gordon William Rewcastle, Julie Ann Spicer, Stephen Douglas Barrett, Michael David Kaufman, Jared Bruce John Milbank, Haile Tecle
  • N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
    Publication number: 20030232889
    Abstract: The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions, and methods of use thereof.
    Type: Application
    Filed: January 23, 2003
    Publication date: December 18, 2003
    Inventors: Stephen Douglas Barrett, Michael David Kaufman, Gordon William Rewcastle, Julie Ann Spicer